FDA defends generic drug label proposal at U.S. House hearing

[Reuters] – The U.S. Food and Drug Administration on Tuesday defended its proposal to require generic drugmakers to update the prescribing information on their products if they become aware of new safety information, a move the industry says will open th more

View todays social media effects on MYL

View the latest stocks trending across Twitter. Click to view dashboard

See who Mylan is hiring next, click here to view